Cephalexin

Product NDC
68788-9539
11-digit product format
687889539
Labeler code
68788
Product ID
68788-9539_8b197230-f3f8-48ac-9d94-b98a203dbd63
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Cephalexin
Dosage form
POWDER, FOR SUSPENSION
Route
ORAL
Labeler
Preferred Pharmaceuticals, Inc.
Application
ANDA062703
Marketing category
ANDA
Marketing start
2013-12-03
Marketing end
0000-00-00
Substance
CEPHALEXIN
Active strength
250 mg/5mL
Pharmacologic classes
Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct68788-9539DDiscontinued by firm2026-08-17
excluded packagepackage68788-953968788-9539-1DDiscontinued by firm2026-08-17
excluded packagepackage68788-953968788-9539-2DDiscontinued by firm2026-08-17

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A062703-001CEPHALEXINCEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB1987-02-13
A062703-002CEPHALEXINCEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALABRS1987-02-13

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-productTE code
A062703-001AB
A062703-002AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-18 06:07:402026-07A062703-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB1987-02-13caaa826d4ba7…
2026-08-18 06:07:402026-07A062703-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALABRS1987-02-13caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A062703-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB1987-02-13011fe1cb6892…
2026-02-19 14:30 UTC2026-02A062703-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALABRS1987-02-13011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A062703-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB1987-02-1331067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A062703-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALABRS1987-02-1331067a03dcf5…
2025-08-23 18:47 UTC2025-08A062703-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB1987-02-136a471c1ec25d…
2025-08-23 18:47 UTC2025-08A062703-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALABRS1987-02-136a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A062703-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB1987-02-13fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A062703-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALABRS1987-02-13fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A062703-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB1987-02-13b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A062703-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALABRS1987-02-13b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A062703-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB1987-02-1303ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A062703-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALABRS1987-02-1303ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A062703-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB1987-02-132680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A062703-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALABRS1987-02-132680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A062703-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB1987-02-135bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A062703-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALABRS1987-02-135bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A062703-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB1987-02-13d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A062703-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALABRS1987-02-13d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A062703-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB1987-02-13d06236e962d9…
2024-10-29 15:01 UTC2024-10A062703-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALABRS1987-02-13d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A062703-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB1987-02-1379d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A062703-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALABRS1987-02-1379d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A062703-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB1987-02-13301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A062703-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALABRS1987-02-13301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A062703-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB1987-02-131e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A062703-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALABRS1987-02-131e350fbaab3a…
2024-05-31 18:47 UTC2024-05A062703-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB1987-02-138072bd15b7f6…
2024-05-31 18:47 UTC2024-05A062703-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALABRS1987-02-138072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A062703-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB1987-02-135c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A062703-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALABRS1987-02-135c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A062703-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB1987-02-135d02ea3f76ae…
2022-04-08 23:34 UTC2022-04A062703-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALABRS1987-02-135d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A062703-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB1987-02-134b0b4de00fa7…
2022-04-04 05:41 UTC2022-04A062703-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALABRS1987-02-134b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A062703-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB1987-02-1374a2ff9319b5…
2019-12-13 00:20 UTC2019-12A062703-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALABRS1987-02-1374a2ff9319b5…
2022-03-09 01:35 UTC2022-03A062703-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB1987-02-13bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03A062703-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALABRS1987-02-13bb7c543d1eb4…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-18 06:07:402026-07A062703-001AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A062703-002AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A062703-001AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A062703-002AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A062703-001AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A062703-002AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A062703-001AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A062703-002AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A062703-001AB1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A062703-002AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A062703-001AB1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A062703-002AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A062703-001AB103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A062703-002AB103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A062703-001AB12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A062703-002AB12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A062703-001AB15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A062703-002AB15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A062703-001AB1d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A062703-002AB1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A062703-001AB1d06236e962d9…
2024-10-29 15:01 UTC2024-10A062703-002AB1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A062703-001AB179d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A062703-002AB179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A062703-001AB1301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A062703-002AB1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A062703-001AB11e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A062703-002AB11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A062703-001AB18072bd15b7f6…
2024-05-31 18:47 UTC2024-05A062703-002AB18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A062703-001AB15c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A062703-002AB15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A062703-001AB15d02ea3f76ae…
2022-04-08 23:34 UTC2022-04A062703-002AB15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A062703-001AB14b0b4de00fa7…
2022-04-04 05:41 UTC2022-04A062703-002AB14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A062703-001AB174a2ff9319b5…
2019-12-13 00:20 UTC2019-12A062703-002AB174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A062703-001AB1bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03A062703-002AB1bb7c543d1eb4…

DailyMed Socrata Ingredients#

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
68788-9539CEPHALEXIN POWDER, FOR SUSPENSION [PREFERRED PHARMACEUTICALS, INC.]10Legacy NDC20250223_07631a8b-eb84-46aa-844e-e93e548cb9b2.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CephalexinCEPHALEXINNuCare Pharmaceuticals,Inc.549bf887-1ef6-6a75-e054-00144ff8d46c2024-08-14Warnings, Adverse reactionsExact identifier
application applno (ANDA): 062703
application number: ANDA062703
CephalexinCEPHALEXINProficient Rx LPfebab51b-6b48-488a-8fd1-d24400e5df1d2022-07-01Warnings, Adverse reactionsExact identifier
application applno (ANDA): 062703
application number: ANDA062703
CephalexinCEPHALEXINTeva Pharmaceuticals USA, Inc.19307ff0-71de-477b-965d-ea243e5ede3a2020-12-31Warnings, Adverse reactionsExact identifier
application applno (ANDA): 062703
application number: ANDA062703

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
68788-9539-168788953901100 mL in 1 BOTTLE (68788-9539-1) 100 ml2013-12-030000-00-00NoNoCurrent
68788-9539-268788953902200 mL in 1 BOTTLE (68788-9539-2) 200 ml2013-12-030000-00-00NoNoCurrent